Literature DB >> 23849770

[Interleukin-1 and the interleukin-1 receptor antagonist gene polymorphisms study in patients with rheumatoid arthritis].

I Allam1, R Djidjik, N Ouikhlef, S Louahchi, N Raaf, N Behaz, A Abdessemed, N Khaldoun, A Tahiat, M Bayou, A Ladjouze-Rezig, M Ghaffor.   

Abstract

OBJECTIVES: One of the most important pro-inflammatory cytokines in the pathophysiology of rheumatoid arthritis (RA) is interleukin 1 (IL-1). The purpose of this study is to evaluate the association between IL-1B (-511), IL-1 (+3953), IL-1 RN variable number of tandem repeat (VNTR) polymorphisms and the occurrence in Algerian patients with rheumatoid arthritis. We also analyze their correlations with clinical and biological phenotypes. PATIENTS AND METHODS: One hundred and forty-seven patients with RA (119 women, 28 men) and 127 controls (70 women, 57 men) were included in the study. The analysis of two polymorphisms of IL-1B-511 and IL-1B+3953 was done by PCR-RFLP. Analysis of IL1-RN VNTR polymorphism was performed by PCR.
RESULTS: No significant difference in genotype, allelic and haplotype distribution at the three polymorphisms was observed between RA patients and controls. However, the genotype (T/T) polymorphism of IL-1B-511 is more frequent in the group of patients with positive ACPA compared with negative ACPA group (Pc=0.01, OR=4.65). Moreover, we noted that the haplotype (IL-1RN* 1/IL-1B-511T/IL-1B+3953C) was more frequent (Pc=0.03, OR=2.05) in the positive ACPA group.
CONCLUSION: The association between the allele 1 of IL-1 RN VNTR, T allele of IL1B-511 and C allele of IL1-B +3953 polymorphisms seems to predispose to the synthesis of ACPA and therefore to the occurrence of ACPA positive RA. Further studies with a larger number of patients are needed to define the real role of IL-1 in the susceptibility to or severity of RA.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-citrullinated protein autoantibody; Anticorps anti-peptides citrullinés; IL-1; IL1-RN; Polyarthrite rhumatoïde; Polymorphism; Polymorphisme; Rheumatoid arthritis

Mesh:

Substances:

Year:  2013        PMID: 23849770     DOI: 10.1016/j.patbio.2013.05.005

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  4 in total

1.  Association of 86 bp variable number of tandem repeat (VNTR) polymorphism of interleukin-1 receptor antagonist (IL1RN) with susceptibility and clinical activity in rheumatoid arthritis.

Authors:  S Ramírez-Pérez; M Salazar-Páramo; S Pineda-Monjarás; U De la Cruz-Mosso; J Hernández-Bello; G E Martínez-Bonilla; A L Pereira-Suárez; J F Muñoz-Valle
Journal:  Clin Rheumatol       Date:  2017-03-25       Impact factor: 2.980

2.  Pro-inflammatory cytokine response pre-dominates immuno-genetic pathway in development of rheumatoid arthritis.

Authors:  E K Krishna Priya; Lekshmy Srinivas; S Rajesh; Kesavarao Sasikala; Moinak Banerjee
Journal:  Mol Biol Rep       Date:  2020-10-19       Impact factor: 2.316

Review 3.  Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.

Authors:  Lili Magyari; Dalma Varszegi; Erzsebet Kovesdi; Patricia Sarlos; Bernadett Farago; Andras Javorhazy; Katalin Sumegi; Zsolt Banfai; Bela Melegh
Journal:  World J Orthop       Date:  2014-09-18

Review 4.  Ultra-Low Dose Cytokines in Rheumatoid Arthritis, Three Birds with One Stone as the Rationale of the 2LARTH® Micro-Immunotherapy Treatment.

Authors:  Camille Jacques; Ilaria Floris; Béatrice Lejeune
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.